NCT06554496 - XOR Levels in OSA Patients (XOR-OSA) | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

July 1, 2024

Primary Completion Date

August 1, 2025

Study Completion Date

December 31, 2025

Conditions

Obstructive Sleep Apnea

Interventions

DEVICE

CPAP Treatment

Continuous Positive Airway Pressure (CPAP) therapy will be administered to patients for 3 months. The CPAP device will be set to deliver a continuous flow of air at a prescribed pressure to keep the patient's airway open during sleep.

Trial Locations (1)

210029

RECRUITING

The First Affiliated Hospital of Nanjing Medical University, Nanjing